| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 268.00M | — |
| Operating expense | — | — |
| Net income | -115.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, IONS returned +39.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -24.5% |
| 1 year | +39.9% |
| 5 years | +50.3% |
| 10 years | +101.5% |
| All-time high | $82.73 (Nov 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in IONS would be worth today ›No. Ionis Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Ionis Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol IONS.
Ionis Pharmaceuticals, Inc. is part of the Healthcare sector.
Ionis Pharmaceuticals, Inc. has a market cap of 9.93B USD, based on the latest quote.
